1. |
中华医学会肝病学分会、传染病学分会. 慢性乙型肝炎防治指南[J]. 中华肝脏病杂志, 2005, 13(12): 881-891.
|
2. |
中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志, 2000, 8(6): 342-329.
|
3. |
Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences[J]. N Engl J Med, 2004, 350(11): 1118-1129.
|
4. |
World Health Organization. Hepatitis B (Revised August 2008)(2010-12-09)[2011-09-24].[EB/OL]. http://www.who.int/medicacentre/fact-sheets/fs204/en/.
|
5. |
European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B[J]. J Hepatol, 2009, 50 (2): 227-242.
|
6. |
Liu Y, Wang CM, Cheng J, et al. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility[J]. Chin Med J (Engl) 2009,122 (13): 1585-1586.
|
7. |
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures[J]. J Viral Hepatitis, 2004, 11 (2): 97-107.
|
8. |
叶任高. 内科学[M]. 6版. 北京: 人民卫生出版社, 2003: 303.
|
9. |
戴万亨. 中西医临床内科学[M]. 北京: 中国医药科技出版社, 2003: 39-41.
|
10. |
王伯祥. 慢性乙型肝炎中医药证治研究进展[J]. 世界中医药, 2007, 1(2): 61-62.
|
11. |
《中医药创新与发展》编委会. 中医药防治在重大传染病的研究[M]. 成都:四川科学技术出版社, 2010: 105-240.
|